Non-Alcoholic Steatohepatitis Biomarkers Market Trends 2022 : Analysis of Key Players, Opportunities, consumption by Regional data, Size and Share, Growth by New Techniques and Forecast to 2031

Kenneth Research, in its repository of market research reports, has recently added a report on the Non-Alcoholic Steatohepatitis Biomarkers Market that emphasizes the latest trends, key opportunities, drivers, and challenges associated with the growth of the market during the forecast period, i.e., 2022 – 2031. The Non-Alcoholic Steatohepatitis Biomarkers Market is anticipated to grow primarily on account of the growing trade of ICT goods and services worldwide. According to the statistics by the World Bank, the exports of ICT goods globally increased from 11.164% of total goods exports in 2017 to 11.53% of total goods exports in 2019.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analysis and U.S. Census Bureau mention the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) average exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilst imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Non-Alcoholic Steatohepatitis Biomarkers Market products.

Download Sample of This Strategic Report-

In 2018, the worldwide GDP stood at USD 84,740.3 Billion as compared to the GDP of USD 80,144.5 Billion in 2017, marked a growth of 5.73% in 2018 over previous year according to the data quoted by International Monetary Fund. This is likely to impel the growth of Non-Alcoholic Steatohepatitis Biomarkers Market over the period 2019-2024.

The Non-Alcoholic Steatohepatitis Biomarkers Market report also focuses on the analysis on the basis of geography which includes North America (U.S. and Canada), Latin America (Mexico, Brazil, Argentina, Rest of Latin America), Europe (Germany, UK, France, Spain, Italy, NORDIC, BENELUX, Poland, Russia, Hungary, Rest of Europe), Asia Pacific (China, Japan, India, Australia, New Zealand, South Korea, Malaysia, Indonesia, Rest of Asia Pacific) and Middle East and Africa (GCC, North Africa, South Africa and Rest of Middle East and Africa).

In U.S., the GDP per capita was valued at USD 62,606 in 2018 as compared to USD 59,895 marked in 2017, observed a growth of 4.53% in 2018 over previous year. Rise in GDP per capita has intensified the growth of this market in the country.

Market Overview

The Global Non-Alcoholic Steatohepatitis Biomarkers Market is Expected to Register a CAGR of 20.92% and is Anticipated to Reach USD 1,960.4 million by 2024. Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD), which is characterized by liver inflammation and damage caused by a buildup of fat in the liver. Currently, there is no single test approved for diagnosing non-alcoholic steatohepatitis.

Download Sample of This Strategic Report-

The major factors characterizing the growth of the global non-alcoholic steatohepatitis biomarkers market are the increasing prevalence of NASH, growing demand for non-invasive diagnostic tests, and rising initiatives for creating awareness. On the contrary, the presence of stringent regulations by the US FDA for the qualification of biomarkers is anticipated to restrict the market growth during the forecast period.

Market Dynamics

The incidence of NASH is increasing at an alarming rate and thus has led to the growing need for effective diagnostic tools in recent years. According to the data published by the NASH Education Program, the prevalence of NASH is anticipated to rise by 63% between 2015 and 2030. Factors such as the increasing prevalence of diabetes and obesity, growing demand for non-invasive tests, and growing public and private sector initiatives to increase awareness about NASH are expected to fuel the growth of the global market. Despite the drivers, the unfavourable regulatory scenario is likely to affect market growth over the forecast period negatively.

Global Non-Alcoholic Steatohepatitis Biomarkers Market Revenue, by End User, 2018—2024 (USD Mn)


The global non-alcoholic steatohepatitis biomarkers market has been segmented into type and end-user. By type, the market has been segmented into serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers, and others. By end-user, the market has been segmented into pharmaceutical companies and CROs, research institutes and academics, hospitals & clinics, diagnostic centres, and others. The pharmaceutical companies and CROs segment accounted for a market value of USD 226.7 million in 2018.

Key Players

The prominent players in the global non-alcoholic steatohepatitis biomarkers market are BioPredictive (France), Celerion (US), Cisbio (France), Echosens (France), Enterome (France), GENFIT (France), Laboratory Corporation of America Holdings (US), NGM Biopharmaceuticals (US), One Way Liver, SL (Spain), Pacific Biomarkers (US), Prometheus Laboratories Inc (US), Perspectrum Diagnostics Ltd (UK), Quest Diagnostics, Regulus Therapeutics, Inc. (US), Siemens Healthineers (Germany), Shenzhen New Industries Biomedical Engineering Co., Ltd (China), and Xeptagen SpA (Italy)

Request Free Sample Copy :-

About Us
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.

Contact Us
Name: Kenneth research
Phone: +1 313 462 0609

Blockchain in Pharmaceutical Supply Chain ManagemenT Market
Automatic Pill Dispenser Market
Nanobiosensors in Healthcare Market
Feminine Hygiene Market
Non-Alcoholic Steatohepatitis Biomarkers Market
Digital Radiology Devices Market

Leave a Reply

Your email address will not be published. Required fields are marked *